Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial

BACKGROUND: There is strong mechanistic evidence to suggest that vitamin D and omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFAs), specifically docosahexaenoic acid (DHA), have the potential to significantly improve the symptoms of autism spectrum disorder (ASD). However, there are no tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazahery, Hajar, Conlon, Cathryn, Beck, Kathryn L., Kruger, Marlena C., Stonehouse, Welma, Camargo, Carlos A., Meyer, Barbara J., Tsang, Bobby, Mugridge, Owen, von Hurst, Pamela R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917935/
https://www.ncbi.nlm.nih.gov/pubmed/27334138
http://dx.doi.org/10.1186/s13063-016-1428-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917935/
https://www.ncbi.nlm.nih.gov/pubmed/27334138
http://dx.doi.org/10.1186/s13063-016-1428-8

Ejemplares similares